男性乳腺癌：重新审视我们的观点。

Kale Santosh, Rammohan Rajmohan, Vas Vilma, Elsayad Chris

Department of Internal Medicine, Nassau University Medical Center, East Meadow, Nassau County, NY, USA.

Case Rep Oncol Med. 2020 Feb 6;2020:6245415. doi: 10.1155/2020/6245415. eCollection 2020.

Male breast cancers (MBCs) are relatively uncommon malignancy with less than 1% incidence. MBC presents at a later age with a more advanced presentation as compared to the female breast cancer. Due to the paucity of the number of cases and trials regarding the MBC, female breast cancer treatment protocols are applied. Mastectomy and hormonal therapy remains the mainstay of treatment. Moreover, the data about prognosis of MBC remains limited.

男性乳腺癌（MBC）是一种相对罕见的恶性肿瘤，发病率低于1%。与女性乳腺癌相比，MBC发病年龄较晚，临床表现更为晚期。由于关于MBC的病例和试验数量较少，因此采用女性乳腺癌的治疗方案。乳房切除术和激素治疗仍然是主要的治疗方法。此外，关于MBC预后的数据仍然有限。